Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma in Hong Kong

作     者：Ka Wing Ma Kenneth Siu Ho Chok James Yan Yue Fung Chung Mau Lo 

作者机构：Department of SurgeryThe University of Hong KongHong KongChina State Key Laboratory for Liver ResearchThe University of Hong KongHong KongChina Department of MedicineThe University of Hong KongHong KongChina 

出 版 物：《Journal of Clinical and Translational Hepatology》 (临床与转化肝病杂志（英文版）)

年 卷 期：2018年第6卷第3期

页      面：283-288页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：Liver transplantation Hepatitis B Hepatocel ular carcinoma Review 

摘      要：Hepatocellular carcinoma(HCC)is the fifth most common cancer and the third most common cause of cancer-related deaths worldwide.Curative resection is frequently limited in Hong Kong by hepatitis B virus-related cirrhosis,and liver transplantation is the treatment of choice.Liver transplanta-tion has been shown to produce superior oncological benefits,when compared to hepatectomy for HCC.New developments in the context of patient selection criteria,modification of organ allocation,bridging therapy,salvage liver transplanta-tion and pharmaceutical breakthrough have improved the survival of HCC patients.In this article,we will share our experience in transplanting hepatitis B virus-related HCC patients in Hong Kong and discuss the recent progress in several areas of liver transplantation.